Ann: Preliminary PAT-DX1 pharmacokinetics, page-24

First 24 Last

Share
Profile

Follow
TraderRR

13,640 Posts.

371

05/07/18

21:14

Post #: 34172949
Share

Originally posted by gassed ↑

Hingdog. After today's announcement, which went much further than an explanation of the technicalities of pharmacokinetics, and actually gave progress developments of that pharmacokinetics, I hazard to guess what will be included in what "looks like" another simple explanation of a complex technicality.
But, my reading of it after today, is that "initiating a stable line development" is not to "initiate" i.e. "cause to begin towards establishing a stable cell line development", but, that they hope to announce that they have actually succeeded in "developing" what they consider to be a very important milestone!! Another huge step forward.

I've said it before that they are very media savvy and they won't waste the cost of an official announcement without getting some leverage out of it. I, frankly, am starting to think that that is why the SP doesn't hold, as the market seems to be getting heaps of teasers which fizz out, but are awaiting something more tangible that THEY can put a $ to and that will be MANY $s the way it's shaping.

These are the sort of frustrations that must be endured when getting involved in any way with this type of biotech research company, but, success will be extremely rewarding. Just being a companion and vehicle for other treatments will be priceless to the pharma giants, let alone being a stand alone cure in its own right.

Expand

market totally missed this ann imo.
late arvo ann 7.6target
traderrr

PAB Price at posting: 5.2¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

TNC

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

WML

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

QGL

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

LML

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

There are more pages in this discussion • 47 more messages in this thread...

First 24 Last

Add PAB (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $6.172M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
34	24699181	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	25889307	17

View Market Depth

No.	Vol.	Price($)
34	24699181	0.003
28	32556332	0.002
12	51351998	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	25889307	17
0.005	10004512	8
0.006	7701466	6
0.007	6601356	5
0.008	790910	3

Last trade - 16.12pm 14/10/2024 (20 minute delay)

PAB (ASX) Chart

Day chart unavailable

Ann: Preliminary PAT-DX1 pharmacokinetics, page-24

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Preliminary PAT-DX1 pharmacokinetics, page-24

Top Stories

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News